Cardio Diagnostics Holdings/$CDIO
1D1W1MYTD1Y5YMAX
About Cardio Diagnostics Holdings
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
- Ticker
- $CDIO
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Chicago, United States
- Website
- cdio.ai
CDIO Metrics
BasicAdvanced
$5.5M
-
-$2.76
2.22
-
Price and volume
Market cap
$5.5M
Beta
2.22
52-week high
$7.91
52-week low
$0.97
Average daily volume
85K
Financial strength
Current ratio
17.149
Quick ratio
15.564
Long term debt to equity
1.893
Total debt to equity
4.978
Interest coverage (TTM)
-525.07%
Profitability
EBITDA (TTM)
-6.084
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-44,771.83%
Operating margin (TTM)
-44,536.55%
Management effectiveness
Return on assets (TTM)
-44.06%
Return on equity (TTM)
-75.44%
Valuation
Price to revenue (TTM)
300.276
Price to book
0.74
Price to tangible book (TTM)
0.85
Price to free cash flow (TTM)
-0.711
Free cash flow yield (TTM)
-140.74%
Free cash flow per share (TTM)
-2.604
Growth
Revenue change (TTM)
-25.92%
Earnings per share change (TTM)
-38.71%
3-year revenue growth (CAGR)
75.46%
3-year earnings per share growth (CAGR)
-60.80%
CDIO News
AllArticlesVideos
Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges
Business Wire3 days ago
Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City
Business Wire2 weeks ago
Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026
Business Wire3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.